Jorge Francisco Chávez, MD
@jofran12Interventional Cardiology fellow at Hospital Clínico San Carlos de Madrid. 🇵🇪🇪🇸
Similar User
@APCyCCV
@Pierocustodio
@EstebanLizbel
@Joseluis_MD29
@LeanMamaniPerez
@paol_rojas
@Juanma_Munoz29
@manuelchacon202
@Walarco1
@mariluzCutipa
🙌😅
Risk stratification for TEER in severe primary MR is challenging. This classification system emphasizing comprehensive cardiac evaluation, especially beyond the mitral valve, may aid in better patient selection and guide intervention timing. ow.ly/vQo550Q6CfJ
Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial: @CircAHA 🥸 Good morning 😱 Few summary points from this sub-analysis from DanGer Shock 👇👇👇
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation: @NEJM 🥸 TRISCEND II Trial - #TCT2024 😱 Summary 👇👇👇
EARLY TAVR published. Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes, driven by the latter. The study's…
👐
👩💻Lunes 14: ⏰ 10hs segundo Caso de cierre de orejuela desde el Hospital Clínico San Carlos de Madrid con @luisnombela @pabl0salinas 🔝 Moderadores : @frenandosarnago @IgnacioSPerez74 ✔️ Link para conectarse ✍️👇👇👇👇@IberiaSmt @LifTechScient e bit.ly/47ECmjX
TRIVALVE Score new ⚙️ for TTV interventions! Easy to calculate 🧐, let’s apply it! @shci_sec sciencedirect.com/science/articl…
🙌😁 #CARDIOCETE
Una nueva edición de CARDIOCETE, éxito de asistentes y gran calidad de ponencias. Una cita imperdible. @secardiologia @shci_sec @SMurCardio @clinica_sec
#Valveday2024 próximo 6 de noviembre “Controversias en valvulopatías” Magnífico programa y panelistas TOP 🔜6 de noviembre 📍Hospital Ramón y Cajal en Madrid 📝Se aceptan casos clínicos 🆓¡Inscripciones gratuitas!
🚨¡Lo más 🔝🔥 del #ESCCongress 2024 en CardioTeca!🚨 En este 🧵resúmenes y comentarios de: 4️⃣ Nuevas Guías 6️⃣5⃣ Estudios/Ensayos Clínicos ⤵️⤵️ 1⃣ Guía ESC 2024 Fibrilación Auricular: Novedades y recomendaciones. cardioteca.com/arritmias/5982… 2⃣ Guía ESC 2024 Síndromes Coronarios…
RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio
Despite the limitations of FFR in aortic stenosis, revascularization based on this index improves the prognosis compared to conservative treatment. PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation | New England Journal of Medicine nejm.org/doi/full/10.10…
🚨Breaking News: New ESC Guidelines on CCS. Intracoronary Imaging now Class IA for LM, true bifurcation and long lesions! Either OCT or IVUS. @PCRonline @escardio @NielsRHolm @twj1974 @nicolasamabile @FBiccire @ziadalinyc @hect2701 @sbrugaletta @HolgerNef
Reshape-HF2 results, M-TEER may be useful for patients with significant non severe MR, specially if they have a previous HF hospitalization #ESCCongress
Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion 👏👏👏 @freixa_xavier @pedro_cepas @ejfu0209 @AnderRegueiro @lsanchisruiz @StructuralBCN @hospitalclinic jamanetwork.com/journals/jamac…
In the BIVOLUTX registry TAVI with the Evolut platform showed promising outcomes for bicuspid aortic valve stenosis, with over 90% device success and sustained valve performance at 1 year. Read the full paper. @didier_tchetche @drnvanmieghem #EIJBestOf #Cardiology #TAVI
Edge-to-edge repair for primary #mitral regurgitation: the good, the bad and the ugly 🔗pcronline.com/Cases-resource… (access via your free My PCR account) Watch the replay 📺 of this practical session to learn how to: 🟣Discover how to select suitable patients for #TEER 🟣Tackle…
🆕 State of the Art DURABILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION TAVI shows promising long-term results, comparable to SAVR, even in younger, low-risk patients. @PPibarot #Cardiology #EAPCI #TAVI #SAVR ow.ly/LCJn50SBTow
Optimal minimal stent area and impact of stent underexpansion in left main up-front 2-stent strategy This study 📊aimed to revise the #IVUS-derived segmental MSA criteria for optimal stent expansion in patients undergoing an up-front 2-#stent strategy using the crush…
You may have heard of the "5-6-7-8" rule for LM-LAD-LCx stent MSAs to reduce long term MACE, but this new study in @CircIntv suggests that bigger MSAs are needed. A new "6-8-12" rule? ahajournals.org/doi/10.1161/CI…).
United States Trends
- 1. Jake Paul 1,03 Mn posts
- 2. #Arcane 202 B posts
- 3. Jayce 40,7 B posts
- 4. Serrano 245 B posts
- 5. #SaturdayVibes 2.380 posts
- 6. Vander 12,8 B posts
- 7. maddie 17,4 B posts
- 8. #HappySpecialStage 73,8 B posts
- 9. Good Saturday 21,1 B posts
- 10. Jinx 96,7 B posts
- 11. #saturdaymorning 1.767 posts
- 12. Canelo 17,5 B posts
- 13. Isha 30,4 B posts
- 14. The Astronaut 27,4 B posts
- 15. #AUSvsPAK 4.433 posts
- 16. Father Time 10,6 B posts
- 17. Super Tuna 20,1 B posts
- 18. Rizwan 7.195 posts
- 19. Logan 78,6 B posts
- 20. Ekko 15,4 B posts
Who to follow
-
Archivos Peruanos Cardiología y Cirugía Cardiovasc
@APCyCCV -
Piero Custodio Sánchez
@Pierocustodio -
Lizbel Esteban
@EstebanLizbel -
José Luis Añorga Ocmin, MD 🇵🇪
@Joseluis_MD29 -
Leandro Mamani Perez
@LeanMamaniPerez -
Paol Rojas
@paol_rojas -
Juan Manuel Muñoz-Moreno, MD, FACC
@Juanma_Munoz29 -
Manuel Chacón Diaz
@manuelchacon202 -
Walarco
@Walarco1 -
Mariluz Cutipa, MD.
@mariluzCutipa
Something went wrong.
Something went wrong.